Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy (Q43540159)
Jump to navigation
Jump to search
scientific article published in January 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy |
scientific article published in January 2001 |
Statements
1 reference
Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy (English)
1 reference
Talvensaari-Mattila A
1 reference
Pääkko P
1 reference
Blanco-Sequeiros G
1 reference
Turpeenniemi-Hujanen T
1 reference
1 January 2001
1 reference
1 reference
65
1 reference
1
1 reference
55-61
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference